Kinetics of Nikkomycin Z Degradation in Aqueous Solution and in Plasma
スポンサーリンク
概要
- 論文の詳細を見る
The stability of nikkomycin Z in aqueous solution at various pH values and in the plasma of several kinds of experimental animals was studied. The degradation of nikkomycin Z in aqueous solution at pH 4 to 11.5 and in plasma was an apparent first-order reaction. The degradation rate at 37℃ increased with increasing pH, from 4.0 to 7.5,and decreased with increasing pH from 7.5 to 10.2. Above pH 10.2,the degradation rate was constant. The maximal rate of nikkomycin Z degradation was observed in pH 7.5 buffer solution, in which the apparent first-order rate constant (k_<obs>) was 8.08×10^<-2>h^<-1> (t_<1/2>=8.6 h). The degradation rate of nikkomycin Z in dog plasma at 37℃ was the almost same as that in pH 7.5 buffer. The rates in rat, mouse, and rabbit plasma were much greater than that in pH 7.5 buffer; the k_<obs> values for rat, mouse, rabbit, and dog plasma at 37℃ were 1.74×10^<-1>min^<-1>, 3.64×10^<-2> min^<-1>, 5.10×10^<-1> h^<-1>, and 6.14×10^<-2> h^<-1>, respectively. The degradation rate of nikkomycin Z in rat plasma was remarkedly decreased when NaF, an esterase inhibitor, was added to the plasma. The findings of faster degradation rates in rat, mouse, and rabbit plasma compared with that in pH 7.5 buffer were considered to be due to an esterase in the plasma. This notion was supported by results showing the degradation rate of nikkomycin Z in porcine liver esterase solution.
- 公益社団法人日本薬学会の論文
- 1997-05-15
著者
-
Horie Toru
Tsukuba Research Laboratories Eisai Co. Ltd.
-
Horie T
Tsukuba Research Laboratories Eisai Co. Ltd.
-
TOKUMURA Tadakazu
Tsukuba Research Laboratories, Eisai Co., Ltd.,
-
Tokumura Tadakazu
Tsukuba Research Laboratories Eisai Co. Ltd.
関連論文
- "S2-5-2) BASIC STRATEGY FOR AVOIDING DRUG INTERACTION DURING STAGE OF DRUG DEVELOPMENT : THE PROPOSALS RELATIVE TO PLANING OF NON-CLINICAL AND CLINICAL STUDIES HOW SHOULD IT BE THE PLANING OF CLINICAL TRIALS (Strategy how we can learn drug-dr
- AUTO-INDUCTION OF E5110 METABOLISM, A NOVEL NON-STEROIDAL ANTI-INFLAMMATORY DRUG, DURING TOXICOKINETIC STUDIES IN BEAGLE DOGS
- Kinetics of Nikkomycin Z Degradation in Aqueous Solution and in Plasma
- Enhancement of Dissolution Rate of 2-[4-(p-Fluorobenzoyl)-piperidin-1-yl]-2'-acetonaphthone Hydrochloride, a Novel Anti-ischemic Drug